APP
ABBV icon

Alpha Paradigm Partners’s AbbVie ABBV Stock Holding History

Alpha Paradigm Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$48K Buy
+295
New +$45.2K 0.02% 424
2021
Q4 		– Sell
-3,251
Closed -$351K – 528
2021
Q3 		$351K Buy
+3,251
New +$371K 0.14% 233
2021
Q1 		– Sell
-1,345
Closed -$144K – 476
2020
Q4 		$144K Buy
+1,345
New +$129K 0.05% 296

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha Paradigm Partners's ABBV Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in AbbVie (ABBV) in Q4 2022: 295 shares worth $48K. The stake represents 0.02% of the portfolio and ranks #424 among its holdings. This is a return to the name: Alpha Paradigm Partners previously reported a position in ABBV as recently as Q3 2021.

Alpha Paradigm Partners first reported a position in ABBV in Q4 2020 and has held it in 3 quarters since. The position peaked at $351K in Q3 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Alpha Paradigm Partners held 295 shares of AbbVie worth $48K as of Q4 2022.
  • AbbVie was a new Alpha Paradigm Partners position in Q4 2022.
  • AbbVie made up 0.02% of Alpha Paradigm Partners's portfolio in Q4 2022, its #424 holding.
  • Alpha Paradigm Partners first reported a position in AbbVie in Q4 2020 and has held it in 3 quarters since.
  • Alpha Paradigm Partners's AbbVie position peaked at $351K in Q3 2021.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.